ArticleCancer research communications2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression.
Mariafausta Fischietti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it